dilluns, 19 de maig del 2014

Activist investor Oracle revives proxy war at Biolase




Oracle Partners issues a public statement to announce its "disappointment" over Biolase's Q1 results, which Biolase chairman & CEO Federico Pignatelli says is more evidence of the firm's attempts to take over the dental devices company.





Activist investor Oracle revives proxy war at Biolase



read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/SbxBaI

Cap comentari:

Publica un comentari a l'entrada